• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Omron

Omron joins $35m Theranica Series B

May 13, 2019 By Fink Densford

Theranica said today that Omron‘s (TYO:6645) venture arm joined a $35 million Series B financing round to support its remote neuromodulation technology. Israel-based Theranica is developing the Nerivio Migra neurostimulation patch intended to treat migraine headache, which is currently under FDA review. Funding in the round, which was initially announced in March, was led by […]

Filed Under: Business/Financial News, Neurological, Neuromodulation/Neurostimulation, Wall Street Beat Tagged With: Omron, Theranica Bio-Electronics

Omron wins FDA nod for combined blood pressure monitor, EKG

March 25, 2019 By Fink Densford

Omron Healthcare (TYO:6645) has won FDA 510(k) clearance for its Blood Pressure Monitor + Echocardiogram device, according to a recently posted FDA release. The device, which was developed in collaboration with AliveCor, allows users to monitor both high blood pressure and atrial fibrillation, which the company said are critical risk factors for stroke. The newly cleared […]

Filed Under: 510(k), Diagnostics, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: AliveCor, Omron

Omron launches HeartGuide watch-based wearable BP monitor

December 27, 2018 By Fink Densford

Omron Healthcare (TYO:6645) said late last week that it launched its HeartGuide wearable blood pressure monitor, touting it as the world’s first such device. The HeartGuide is an FDA-cleared, wearable oscillometric blood pressure monitor intended for personal use and styled to function as a wrist watch, the Lake Forest, Ill.-based company said. The device features a cuff […]

Filed Under: Business/Financial News, Diagnostics, Featured Tagged With: Omron, Omron Healthcare

Omron’s Q1 healthcare sales rise 9%

July 26, 2018 By Brad Perriello

Omron (TYO:6645) today said that sales for its healthcare division grew nearly 9% during its fiscal first quarter. Kyoto, Japan-based Omron, whose largest segment is its industrial automation business, said healthcare sales rose 8.5% to ¥27.9 billion, or roughly $250.2 million, “stemming from favorable sales of blood pressure monitors, nebulizers and low-frequency therapy equipment.” Overall profits […]

Filed Under: MassDevice Earnings Roundup, Wall Street Beat Tagged With: Omron

AngioDynamics CEO DeVivo out, ex-Covidien exec Clemmer in | Personnel Moves for April 4, 2016

April 4, 2016 By Brad Perriello

1. AngioDynamics CEO DeVivo is out, ex-Covidien exec Clemmer is in AngioDynamics (NSDQ:ANGO) said today that president & CEO Joseph DeVivo stepped down to “pursue other interests” and was replaced by ex-Covidien bigwig James Clemmer, effective today. DeVivo joined Latham, N.Y.-based AngioDynamics in September 2011. “We thank Joe for his contributions and commitment to AngioDynamics over […]

Pages: Page 1 Page 2 Page 3 Page 4 Page 5

Filed Under: Business/Financial News Tagged With: AngioDynamics, Baxter, NeoChord Inc., Neural Analytics, Omron, Personnel Moves

NeuroMetrix soars on Japanese market approval of diabetes test

June 24, 2014 By Arezu Sarvestani Leave a Comment

NeuroMetrix soars on Japanese market approval of diabetes test

NeuroMetrix (NSDQ:NURO) got a major Wall Street boost today after announcing Japanese market approval for its NC-stat DPNCheck test for diabetic peripheral neuropathy.

Filed Under: Diagnostics, News Well, Regulatory/Compliance Tagged With: Neurometrix, Omron

Diabetes: NeuroMetrix gains on Chinese distribution deal

December 13, 2013 By Chris Walker

Diabetes: NeuroMetrix gains on Chinese distribution deal

NeuroMetrix (NSDQ:NURO) said it inked a deal with Omron Medical Devices, a subsidiary of Omron Healthcare China, for the distribution rights to NeuroMetrix’s NC-stat DPNCheck in China.

Filed Under: Distribution, News Well, Wall Street Beat Tagged With: Exports, Neurometrix, Omron

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy